These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17460574)

  • 1. N,N,N-trimethylglycine (betaine) improves analysis of CDR3 diversification in children reconstituting their immune repertoire after hematopoietic stem-cell transplantation.
    Terranova MP; Di Michele P; Scuderi F; Valetto A; Di Martino D
    Transplantation; 2007 Apr; 83(7):996-7. PubMed ID: 17460574
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prediction of T-cell immune reconstitution by investigating T cell receptor excision circle and T-cell receptor beta-chain variable region clonal repertoire in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW; Wu DP; Cen JN; Feng YF; Chang WR; Qiu QC; Zhu ZL; Zhu P
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2265-7. PubMed ID: 18001548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated motor polyneuropathy after hematopoietic stem cell transplantation.
    Suzuki S; Mori T; Mihara A; Aisa Y; Ikeda Y; Suzuki N; Okamoto S
    Bone Marrow Transplant; 2007 Aug; 40(3):289-91. PubMed ID: 17502891
    [No Abstract]   [Full Text] [Related]  

  • 4. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: still not out of fashion.
    Doubek M; Folber F; Koristek Z; Brychtova Y; Krejci M; Tomiska M; Navratil M; Mikulasova P; Mayer J
    Ann Hematol; 2009 Sep; 88(9):881-7. PubMed ID: 19172272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
    J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular methods for diagnostics and assessment of treatment effectiveness in modern pediatric hematooncology].
    Dawidowska M; Wachowiak J; Witt M
    Postepy Biochem; 2006; 52(4):408-16. PubMed ID: 17536510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hemopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission-similar outcomes after matched related and unrelated donor transplant: a study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon).
    Muñoz A; Diaz-Heredia C; Diaz MA; Badell I; Verdeguer A; Martinez A; Gomez P; Perez-Hurtado JM; Bureo E; Fernandez-Delgado R; Gonzalez-Valentin ME; Maldonado MS
    Pediatr Hematol Oncol; 2008 Jun; 25(4):245-59. PubMed ID: 18484470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of four MRD markers in MRD-based treatment strategy for childhood acute lymphoblastic leukemia.
    Sawada A; Sakata N; Kishimoto T; Higuchi B; Koyama M; Kondo O; Sato E; Okamura T; Yasui M; Inoue M; Yoshioka A; Kawa K
    Leuk Res; 2009 Dec; 33(12):1710-3. PubMed ID: 19596431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is blood thicker than water?: ethics of hematopoietic stem cell donation by biological siblings of adopted children.
    Kesselheim JC; Lehmann LE; Styron NF; Joffe S
    Arch Pediatr Adolesc Med; 2009 May; 163(5):413-6. PubMed ID: 19414685
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early lymphocyte recovery post-allogeneic hematopoietic stem cell transplantation is associated with significant graft-versus-leukemia effect without increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia.
    Ishaqi MK; Afzal S; Dupuis A; Doyle J; Gassas A
    Bone Marrow Transplant; 2008 Feb; 41(3):245-52. PubMed ID: 17952129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference.
    Locatelli F; Pende D; Maccario R; Mingari MC; Moretta A; Moretta L
    Clin Immunol; 2009 Nov; 133(2):171-8. PubMed ID: 19481979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barre syndrome associated with rapid immune reconstitution following allogeneic hematopoietic stem cell transplantation.
    Fujisaki G; Kami M; Murashige N; Kishi Y; Hori A; Chizuka A; Ugawa Y; Kobayashi K; Tanosaki R
    Bone Marrow Transplant; 2006 Mar; 37(6):617-9. PubMed ID: 16444281
    [No Abstract]   [Full Text] [Related]  

  • 15. Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse.
    Pulsipher MA; Bader P; Klingebiel T; Cooper LJ
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):62-71. PubMed ID: 19147081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-leukemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia: significantly lower relapse rate in unrelated transplantations.
    Gassas A; Sung L; Saunders EF; Doyle J
    Bone Marrow Transplant; 2007 Nov; 40(10):951-5. PubMed ID: 17873916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation for children with acute lymphoblastic leukemia.
    Krance R
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S25-S27. PubMed ID: 18724293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reimmunization after therapy for childhood cancer.
    Chisholm JC
    Clin Infect Dis; 2007 Mar; 44(5):643-5. PubMed ID: 17278053
    [No Abstract]   [Full Text] [Related]  

  • 19. Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.
    Bachanova V; Weisdorf D
    Bone Marrow Transplant; 2008 Mar; 41(5):455-64. PubMed ID: 17968329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.